Etiqueta: osteoarthritis

The adult stem cell product Prochymal, developed by Osiris Therapeutics, is now being used in the treatment of type I diabetes.

A group of veterinarians at Cornell University has conducted a controlled study in which autologous adult stem cells were evaluated in the treatment of tendon injuries in horses.

Osiris Therapeutics begins Phase II clinical trials for its Prochymal adult stem cell therapy in the regeneration of cardiac tissue following myocardial infarction.

Once again, intrepid four-legged patients are blazing new trails in adult stem cell therapy.

Scientists in Scotland have developed a new technique for growing cartilage with adult stem cells.

Unburdened with a canine equivalent of the FDA, elderly dogs in Australia are learning how to be young again, thanks to adult stem cell therapy.

The Australia-based company Mesoblast Limited announces institutional approval to begin the first human clinical trials of adult stem cell treatment for the prevention of osteoarthritis in the knee after acute traumatic injury.

In one of the largest business arrangements ever made, Osiris and Genzyme agree upon a major adult stem cell collaboration.

As crippled horses, dogs and cats show dramatic improvement after being treated with adult stem cell therapy, their progress parallels similar advancements for humans.

Orthopedic surgery may soon be a thing of the past, as biology is replacing metal as the preferred tool in the repair of diseased and injured joints.